ACS Medicinal Chemistry Letters
Letter
(10) Wei, D.; Jiang, X.; Zhou, L.; Chen, J.; Chen, Z.; He, C.; Yang,
K.; Liu, Y.; Pei, J.; Lai, L. Discovery of multitarget inhibitors by
combining molecular docking with common pharmacophore match-
ing. J. Med. Chem. 2008, 51, 7882.
(11) Peters, J.-U.; Hoffmann, T.; Schnider, P.; Stadler, H.; Koblet, A.;
Alker, A.; Poli, S. M.; Ballard, T. M.; Spooren, W.; Steward, L.; Sleight,
A. Discovery of potent, balanced and orally active dual NK1/NK3
receptor ligands. J. Bioorg. Med. Chem. Lett. 2010, 20, 3405.
(12) Knust, H.; Nettekoven, M.; Ratni, H.; Vifian, W.; Wu, X.
Piperidine derivatives as NK3 receptor antagonists. PCT Int. Appl.,
WO2009033995, 2009.
(13) Caroon, J. M.; Dillon, M. P.; Han, B.; Nettekoven, M.; Ratni,
H.; Vifian, W. Spiropiperidine Derivatives as NK3 antagonists. PCT
Int. Appl., WO2008081012, 2008.
(14) Bissantz, C.; Hoffmann, T.; Jablonski, P.; Knust, H.;
Nettekoven, M.; Ratni, H.; Wu, X. Pyrrolidine derivatives as dual
NK1/NK3 receptor antagonists. PCT Int. Appl., WO2008128891,
2008.
(15) Schnider, P. Dual NK1/NK3 antagonists against Schizophremia.
PCT Int. Appl., WO2006013050, 2006.
(16) Hoffmann, T.; Koblet, A.; Peters, J. U.; Schnider, P.; Sleight, A.;
Stadler, H. Dual NK1/NK3 antagonists for treating schizophremia.
PCT Int. Appl.,WO2005002577, 2005.
(17) See also Catalani, M. P.; Alvaro, G.; Bernasconi, G.; Bettini, E.;
Bromidge, S. M.; Heer, J.; Tedesco, G.; Tommasi, S. Identification of
novel NK1/NK3 dual antagonists for the potential treatment of
schizophrenia. Bioorg. Med. Chem. Lett. 2011, 21, 6899.
(18) Aurelio, L.; Brownlee, R. T. C.; Hughes, A. B. Synthetic
preparation of N-methyl-α-amino acids. Chem. Rev. 2004, 104, 5823.
(19) Pasternak, A.; Marino, D.; Vicario, P. P.; Ayala, J. M.; Cascierri,
M. A.; Parsons, W.; Mills, S. G.; MacCoss, M.; Yang, L. Novel, orally
bioavailable γ-aminoamide CC chemokine receptor 2 (CCR2)
antagonists. J. Med. Chem. 2006, 49, 4801.
(20) Shah, S. K.; Chen, N.; Guthikonda, R. N.; Mills, S. G.;
Malkowitz, L.; Springer, M. S.; Gould, S. L.; DeMartino, J. A.; Carella,
A.; Carver, G.; Holmes, K.; Schleif, W. A.; Danzeisen, R.; Hazuda, D.;
Kessler, J.; Lineberger, J.; Miller, M.; Emini, E. A.; MacCoss, M.
Synthesis and evaluation of CCR5 antagonists containing modified 4-
piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane. Bioorg. Med.
Chem. Lett. 2005, 15, 977.
(21) Dorn, C. P.; Finke, P. E.; Oates, B.; Budhu, R. J.; Mills, S. G.;
MacCoss, M.; Malkowitz, L.; Springer, M. S.; Daugherty, B. L.; Gould,
S. L.; DeMartino, J. A.; Siciliano, S. J.; Carella, A.; Carver, G.; Holmes,
K.; Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.;
Schleif, W. A.; Emini, E. A. Antagonists of the human CCR5 receptor
as anti-HIV-1 agents. Part 1: Discovery and initial structure−activity
relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes. Bioorg.
Med. Chem. Lett. 2001, 11, 259.
(22) Finke, P. E.; Meurer, L. C.; Oates, B.; Mills, S. G.; MacCoss, M.;
Malkowitz, L.; Springer, M. S.; Daugherty, B. L.; Gould, S. L.;
DeMartino, J. A.; Siciliano, S. J.; Carella, A.; Carver, G.; Holmes, K.;
Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.;
Schleif, W. A.; Emini, E. A. Antagonists of the human CCR5 receptor
as anti-HIV-1 agents. Part 2: Structure−activity relationships for
substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperi-
din-1-yl)butanes. Bioorg. Med. Chem. Lett. 2001, 11, 265.
(23) Hale, J. J.; Finke, P. E.; MacCoss, M. A facile synthesis of the
novel Neurokinin A antagonist SR 48968. Bioorg. Med. Chem. Lett.
1993, 3, 319.
(27) Lundin, P. M.; Fu, G. C. Asymmetric Suzuki cross-couplings of
activated secondary alkyl electrophiles: arylations of racemic α-
chloroamides. J. Am. Chem. Soc. 2010, 132, 11027.
(28) Andrus, M. B.; Harper, K. C.; Christiansen, M. A.; Binkley, M.
A. Phase-transfer catalyzed asymmetric arylacetate alkylation. Tetrahe-
dron Lett. 2009, 50, 4541.
(29) Dai, X.; Strotman, N. A.; Fu, G. C. Catalytic asymmetric Hiyama
cross-couplings of racemic α-bromo esters. J. Am. Chem. Soc. 2008,
130, 3302.
(30) Krapcho, A. P.; Kuell, C. S. Mono-protected diamines. N-tert-
Butoxycarbonyl-α,ω-alkanediamines from α,ω-alkanediamines. Synth.
Commun. 1990, 20, 2559.
(31) Krivickas, S. J.; Tamanini, E.; Todd, M. H.; Watkinson, M.
Effective methods for the biotinylation of azamacrocycles. J. Org.
Chem. 2007, 72, 8280.
(32) Hughes, A. B.; Sleebs, B. E. Effective methods for the synthesis
of N-methyl β-amino acids from all twenty common α-amino acids
using 1,3-oxazolidin-5-ones and 1,3-oxazinan-6-ones. Helv. Chim. Acta
2006, 89, 2611.
(33) Freidinger, R. M.; Hinkle, J. S.; Perlow, D. S.; Arison, B. H.
Synthesis of 9-fluorenylmethyloxycarbonyl-protected N-alkyl amino
acids by reduction of oxazolidinones. J. Org. Chem. 1983, 48, 77.
(34) Scott, D. E.; Coyne, A. G.; Hudson, S. A.; Abell, C. Fragment-
based approaches in drug discovery and chemical biology. Biochemistry
2012, 51, 4990.
(35) Castro, B.; Dormoy, J. R.; Evin, G.; Selve, C. Reactifs de
couplage peptidique I (1)-l′hexafluorophosphate de benzotriazolyl N-
oxytrisdimethylamino phosphonium (B.O.P.). Tetrahedron Lett. 1979,
16, 1219.
(36) Evans, D. A.; Fu, G. C.; Hoveyda, A. H. Rhodium(I)- and
iridium(I)-catalyzed hydroboration reactions: scope and synthetic
applications. J. Am. Chem. Soc. 1992, 114, 6671.
(37) Evans, D. A.; Fu, G. C.; Anderson, B. A. Mechanistic study of
the rhodium(I)-catalyzed hydroboration reaction. J. Am. Chem. Soc.
1992, 114, 6679.
(38) Dess, D. B.; Martin, J. C. A useful 12-I-5 triacetoxyperiodinane
(the Dess−Martin periodinane) for the selective oxidation of primary
or secondary alcohols and a variety of related 12-I-5 species. J. Am.
Chem. Soc. 1991, 113, 7277.
(39) Dess, D. B.; Martin, J. C. Readily accessible 12-I-5 oxidant for
the conversion of primary and secondary alcohols to aldehydes and
ketones. J. Org. Chem. 1983, 48, 4155.
(40) Masse, J.; Langlois, N. Synthesis of 5-amino and 4-hydroxy-2-
́
phenylsulfonylmethylpiperidines. Heterocycles 2009, 77, 417.
(41) Hattori, K.; Sajiki, H.; Hirota, K. Pd/C(en)-Catalyzed
chemoselective hydrogenation with retention of the N-Cbz protective
group and its scope and limitations. Tetrahedron 2000, 56, 8433.
(42) Boyer, N.; Gloanec, P.; De Nanteuil, G.; Jubault, P.; Quirion, J.-
C. Synthesis of α,α-difluoro-β-amino esters or gem-difluoro-β-lactams
as potential metallocarboxypeptidase inhibitors. Eur. J. Org. Chem.
2008, 4277.
(43) Liu, K. G.; Robichaud, A. J. Synthesis of 3,3-disubstituted
oxindoles. Tetrahedron Lett. 2007, 48, 461.
(44) Teng, D.; Zhang, H.; Mendonca, A. An efficient synthesis of a
spirocyclic oxindole analogue. Molecules 2006, 11, 700.
(45) Bignan, G. C.; Battista, K.; Connolly, P. J.; Orsini, M. J.; Liu, J.;
Middleton, S. A.; Reitz, A. B. Preparation of 3-spirocyclic indolin-2-
ones as ligands for the ORL-1 receptor. Bioorg. Med. Chem. Lett. 2005,
15, 5022.
(24) Harvey, J. S.; Simonovich, S. P.; Jamison, C. R.; MacMillan, D.
W. C. Enantioselective α-arylation of carbonyls via Cu(I)-bisoxazoline
catalysis. J. Am. Chem. Soc. 2011, 133, 13782.
(25) Bigot, A.; Williamson, A. E.; Gaunt, M. J. Enantioselective α-
arylation of N-acyloxazolidinones with copper(II)-bisoxazoline cata-
lysts and diaryliodonium salts. J. Am. Chem. Soc. 2011, 133, 13778.
(26) Owston, N. A.; Fu, G. C. Asymmetric alkyl−alkyl cross-
couplings of unactivated secondary alkyl electrophiles: stereo-
convergent suzuki reactions of racemic acylated halohydrins. J. Am.
Chem. Soc. 2010, 132, 11908.
(46) Freund, R. A convenient synthetic route to spiro[indole-3,4′-
piperidin]-2-ones. Helv. Chim. Acta 2000, 83, 1247.
(47) Clark, R. D.; Caroon, J. M.; Kluge, A. F.; Repke, D. B.;
Roszkowski, A. P.; Strosberg, A. M.; Baker, S.; Bitter, S. M.; Okada, M.
D. Synthesis and antihypertensive activity of 4′-substituted spiro[4H-
3,1-benzoxazine-4,4′-piperidin]-2(1H)-ones. J. Med. Chem. 1983, 26,
657.
(48) Nicolaou, K. C.; Krasovskiy, A.; Trepanier, V. E.; Chen, D. Y.-K.
́
An expedient strategy for the synthesis of tryptamines and other
heterocycles. Angew. Chem., Int. Ed. 2008, 47, 4217−4220.
554
dx.doi.org/10.1021/ml400528y | ACS Med. Chem. Lett. 2014, 5, 550−555